SCHEMBL578322

SCHEMBL578322

N#Cc1csc(-c2c(Cl)[c]nc3ccccc23)n1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL578381 0.87
SCHEMBL578323 0.83 MAOA (0.37) KDM4EALDH1A1
SCHEMBL578087 0.76 NPC1 (0.36) ALDH1A1
SCHEMBL1232940 0.74 TDP1 (0.33) ALDH1A1
SCHEMBL578382 0.72 MAOA (0.36) ALDH1A1
SCHEMBL25412671 0.71 PSMB8 (0.42) ALDH1A1
SCHEMBL16516559 0.67 ALOX15 (0.50) KDM4EALDH1A1
SCHEMBL577631 0.67
SCHEMBL27669614 0.66 KDM4E (0.49) KDM4EALDH1A1
SCHEMBL24181608 0.64 HTR2C (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP claimed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO claimed